Why the study?
Is remote patient monitoring cost-effective for the management of cardiovascular disease in the United States?
Is remote patient monitoring cost-effective for the management of cardiovascular disease in the United States?
Remote patient monitoring is a potentially cost-effective tool for long-term cardiovascular disease management in the US, though more rigorous economic analyses are needed.
Answers are grounded in this paper and cite their sources.
Supports remote patient monitoring consideration in long-term CVD management; extends economic evaluations but leaves open need for rigorous US analyses.
Full economic evaluations identified RPM as a potentially cost-effective tool, particularly for long-term CVD management. In addition to the current literature, rigorous economic analysis with a broader perspective is needed in evaluating the value and economic sustainability of RPM.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: